Group items tagged

The University of Chicago is offering talented individuals from traditionally underrepresented populations an expenses-paid opportunity to explore graduate education at the University of Chicago. Join us for a weekend of graduate admissions workshops, presentations by world-renowned faculty and their graduate students, and informal socials. Receive advice on submitting a competitive application to graduate programs and learn how to develop your own career as a scientist, academic, or professional.

The objective of FDA's Orphan Products Natural History Grants Program is to support studies that characterize the natural history of rare diseases/conditions, identify genotypic and phenotypic subpopulations, and develop and/or validate clinical outcome measures, biomarkers and/or companion diagnostics. The ultimate goal of these natural history studies is to support clinical development of products for use in serious rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA provides grants for natural history studies that will either assist or substantially contribute to market approval of these products. Applicants must include in the application's Background and Significance section documentation to support that the estimated prevalence of the orphan disease or condition in the US is less than 200,000 (or in the case of a vaccine or diagnostic, information to support that the product will be administered to fewer than 200,000 people in the US per year), and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.  Additional information may be required upon request, for example, regarding population estimate and rationale.

Submissions are being accepted for the Annals of Science best paper prize 2014. This prize is awarded annually to the author of an original, unpublished essay in the history of science or technology, which is not under consideration for publication elsewhere. The prize, which is supported by Taylor & Francis, is intended for those who are currently doctoral students, or have been awarded their doctorate within the past four years.

The Science, Technology, and Society (STS) program supports research that uses historical, philosophical, and social scientific methods to investigate the intellectual, material, and social facets of the scientific, technological, engineering and mathematical (STEM) disciplines. It encompasses a broad spectrum of STS topics including interdisciplinary studies of ethics, equity, governance, and policy issues that are closely related to STEM disciplines, including medical science.

To that end, the collaboration will award grants of up to $186,000 over three years to support independent research on topics related to the origins of life at one or more laboratories or research institutions in any country. SCOL seeks to engage the ideas and creativity of researchers around the world and provide opportunities for investigators to interact with their colleagues in different disciplines and programs. Simons Investigators will be expected to participate fully in SCOL events both online and in person (e.g., webinars, workshops, quarterly meetings and annual symposia). These opportunities are designed to both strengthen the collaboration and provide the most fruitful mechanism for bringing a growing origins-of-life community together. Applications from all origins-related disciplines are encouraged.